The word 'agenda' always gets rolled out when no response can be made to accurate criticisms of the company and its management.
The 'big blow' is that the company has managed to get 5 FDA clearances over sixteen years for products based on an innovative technology, and all shareholders have to show for it is about .0001 per clearance.
Another load of absolute nonsense. The deck was pretty clear when the VA was brought on board. Where's the sales? The deck was pretty clear when B. Braun was signed. Where's the sales? The deck was pretty clear when Mundi was signed. Where's the sales? The deck was pretty clear when the NHS was in play. Where's the sales? The deck was pretty clear when teh CE mark was allowed to expire. Where is the CE Mark today?
The deck was completely clear when some company handed KW a 'deal' four weeks ago and she decided to get better terms..... Where's the deal - and the sales?
At least 'big blow' is useful - certainly applies to the performance of BIEL and its management.